Novo Nordisk shares tumble after company warns of sales hit this year

The company is banking on its Wegovy pill and next-generation weight loss injectable CagriSema to recapture share of the key U.S. market.   

Leave a Reply

Your email address will not be published. Required fields are marked *

Sign Up For Real Ac.